User profiles for "author:B Porter"

BRYAN PORTER

Verified email at odu.edu
Cited by 3004

Critical review of behavioral interventions to preserve the environment: Research since 1980

WO Dwyer, FC Leeming, MK Cobern… - Environment and …, 1993 - journals.sagepub.com
This review integrates and evaluates the environmental-preservation research published
during the 1980s. The focus is environmental behavior change as targeted by behavior …

Outcome research in environmental education: A critical review

FC Leeming, WO Dwyer, BE Porter… - The Journal of …, 1993 - Taylor & Francis
This review includes an analysis of the 34 environmental education studies published since
1974 that attempted to demonstrate changes in environmentally relevant knowledge …

[HTML][HTML] Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization …

C Satzke, P Turner, A Virolainen-Julkunen, PV Adrian… - Vaccine, 2013 - Elsevier
Abstract In 2003 the World Health Organization (WHO) convened a working group and
published a set of standard methods for studies measuring nasopharyngeal carriage of …

[HTML][HTML] The draft genome of the transgenic tropical fruit tree papaya (Carica papaya Linnaeus)

…, R Navajas-Pérez, MJ Torres, FA Feltus, B Porter… - Nature, 2008 - nature.com
Papaya, a fruit crop cultivated in tropical and subtropical regions, is known for its nutritional
benefits and medicinal applications. Here we report a 3× draft genome sequence of …

Conservation status of imperiled North American freshwater and diadromous fishes

HL Jelks, SJ Walsh, NM Burkhead… - Fisheries, 2008 - Taylor & Francis
This is the third compilation of imperiled (ie, endangered, threatened, vulnerable) plus
extinct freshwater and diadromous fishes of North America prepared by the American …

[HTML][HTML] Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis

…, P Emery, A Deodhar, B Porter… - New England journal …, 2015 - Mass Medical Soc
Background Secukinumab is an anti–interleukin-17A monoclonal antibody that has been
shown to control the symptoms of ankylosing spondylitis in a phase 2 trial. We conducted …

Programmed contraction of CD8+ T cells after infection

VP Badovinac, BB Porter, JT Harty - Nature immunology, 2002 - nature.com
The extent of infection and rate of pathogen clearance are thought to determine both the
magnitude of antigen-specific CD8+ T cell expansion and the ensuing contraction to a stable …

Intertrochanteric femoral fractures. Mechanical failure after internal fixation

TR Davis, JL Sher, A Horsman… - The Journal of Bone …, 1990 - boneandjoint.org.uk
In a prospective study we assessed the causes of mechanical failure in a series of 230
intertrochanteric femoral fractures which had been internally fixed with either a sliding hip …

Marital discord and childhood behavior problems

B Porter, KD O'Leary - Journal of abnormal child psychology, 1980 - Springer
Measures of overt marital hostility, general marital adjustment, and children's behavior
problems were obtained from the parents of 64 children referred to a child psychological …

[HTML][HTML] Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

…, S Glenn, G Butchko, D Fisher, B Porter… - … England Journal of …, 1993 - Mass Medical Soc
Background Radiolabeled monoclonal antibodies recognizing B-lymphocyte surface
antigens represent a potentially effective new therapy for lymphomas. We assessed the …